Efficacy and safety of vancomycin-loaded calcium sulfate versus conventional surgical debridement for pediatric acute osteomyelitis: a retrospective study

• Published in: BMC musculoskeletal disorders 2022-12, Vol.23 (1), p.1124-1124, Article 1124
• Main Authors: Wang, Biao, Cheng, Weyland, Liu, Fangna, Guo, Zhanhao, Ji, Zejuan, Sun, Keming, Yao, Manye
• Format: Article
• Language: English
• Subjects: Acute hematogenous osteomyelitis; Anti-Bacterial Agents - adverse effects; Calcium; Calcium Sulfate - adverse effects; Care and treatment; Child; Debridement - methods; Demographic aspects; Diagnosis; Humans; Localized antibiotic delivery; Negative-pressure wound therapy; Osteomyelitis; Osteomyelitis - drug therapy; Osteomyelitis - surgery; Parenteral therapy; Retrospective Studies; vancomycin; Vancomycin - adverse effects
• ISSN: 1471-2474; 1471-2474
• DOI: 10.1186/s12891-022-06105-y

The purpose of this study was to evaluate the safety and efficacy of vancomycin-loaded calcium sulfate beads and negative-pressure wound therapy (NPWT) in treating children with acute hematogenous osteomyelitis (AHOM). A retrospective cohort study was conducted from January 2017 to January 2020 examining children (n = 60) with AHOM who were treated with surgical debridement followed by vancomycin-loaded calcium sulfate beads and NPWT (n = 32) and compared to treatment by conventional surgical debridement (n = 28) followed by NPWT. Conventional surgical treatment consisted of fenestration of necrotic infected bone, debridement of surrounding soft tissue, and washing of the medullary canal before the application of NPWT. In the vancomycin group, the antibiotic-loaded beads were implanted after washing the medullary canal and before the application of NPWT. Epidemiological factors, complications during the procedure, outcomes at last follow-up (30.0 ± 11.7 months, range 13-58 months), and laboratory parameters were documented and compared between the two groups. Good outcomes were achieved at last follow-up in 71.4% of the conventional treatment group and 75% of the vancomycin group. In the vancomycin group, it took a mean of 4.8 ± 2.5 days for CRP levels to decrease to 50% of initial inflammatory levels compared to 13 ± 9.6 days for the conventional treatment group (p = 0.001, t-test). The conventional group also had seven patients who underwent four or more surgeries whereas no patients in the vancomycin group underwent more than three surgeries (p = 0.013, chi-square test). Localized vancomycin delivery with NPWT effective for treating cases of AHOM that required. No perioperative adverse reactions or complications occurred from this treatment method. Based on the shortened recovery period of CRP levels, prolonged administration of post-operational parenteral antibiotics can possibly be reduced with this treatment method.